Pharmacokinetics of remimazolam after intravenous infusion in anaesthetised children.
CNS7054
benzodiazepine
children
metabolite
paediatric anaesthesia
pharmacokinetics
remimazolam
Journal
British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
17
05
2023
revised:
19
07
2023
accepted:
03
08
2023
medline:
27
10
2023
pubmed:
23
9
2023
entrez:
22
9
2023
Statut:
ppublish
Résumé
The pharmacokinetic properties of the new benzodiazepine remimazolam have been studied only in adults. We investigated the pharmacokinetics of remimazolam after i.v. infusion in anaesthetised paediatric patients. Twenty-four children (2-6 yr, ASA physical status 1-2, BMI 15-18 kg m Pharmacokinetics were best described by a three-compartment model for remimazolam and a two-compartment model for CNS7054 linked by a transit compartment. Remimazolam showed a high clearance of 15.9 (12.9, 18.2) ml kg Remimazolam in children was characterised by a high clearance and short context-sensitive half-time. When normalised to weight, pharmacokinetic properties were similar to those reported for adults. ChiCTR2200057629.
Sections du résumé
BACKGROUND
The pharmacokinetic properties of the new benzodiazepine remimazolam have been studied only in adults. We investigated the pharmacokinetics of remimazolam after i.v. infusion in anaesthetised paediatric patients.
METHODS
Twenty-four children (2-6 yr, ASA physical status 1-2, BMI 15-18 kg m
RESULTS
Pharmacokinetics were best described by a three-compartment model for remimazolam and a two-compartment model for CNS7054 linked by a transit compartment. Remimazolam showed a high clearance of 15.9 (12.9, 18.2) ml kg
CONCLUSIONS
Remimazolam in children was characterised by a high clearance and short context-sensitive half-time. When normalised to weight, pharmacokinetic properties were similar to those reported for adults.
CLINICAL TRIAL REGISTRATION
ChiCTR2200057629.
Identifiants
pubmed: 37739904
pii: S0007-0912(23)00472-5
doi: 10.1016/j.bja.2023.08.019
pii:
doi:
Substances chimiques
Benzodiazepines
12794-10-4
remimazolam
7V4A8U16MB
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
914-920Informations de copyright
Copyright © 2023 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.